Please ensure Javascript is enabled for purposes of website accessibility

Coronavirus Fears Drive Cannabis Delivery Sales Higher

By Cory Renauer - Mar 16, 2020 at 4:00PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Recreational marijuana consumers, like all the rest of us, are stuck at home.

The nation's rapid shift into social distancing and isolation has been lousy for most segments of the U.S. economy, but one niche seeing significant growth in recent days is the licensed cannabis sector, home to companies like Curaleaf (CURLF 7.38%), and Cresco Labs (CRLBF 2.76%)

During the week that ended March 13, retail locations across the country's largest legal cannabis market, California reported increasing delivery sales. Employees at privately held Ganja Goddess, a delivery service provider operating in California, say they have seen a 10% increase in sales each week for the past three weeks.

Cannabis in a shopping cart.

Image source: Getty Images.

California declared a state of emergency on March 4 after reporting the state's first death from a COVID-19 infection. In Florida, another state where Curaleaf and Cresco have significant operations, Gov. Ron DeSantis on March 7 escalated the state of emergency from level one to level two.

First-timers

Delivery services have in recent years become the norm for most retail products, but cannabis consumers generally want to see what they're buying up close before committing to a purchase. However, the COVID-19 fear hanging over the country like a dark cloud might be just what it takes to push cannabis buyers to try a dispensary-associated delivery service for the first time.

Either way, it could be a while before investors know if the publicly traded cannabis producers are experiencing a social-distancing-induced sales bump. On March 24, 2020, Curaleaf will report results from the fourth quarter of 2019, and Cresco Labs hasn't announced a date for its fourth-quarter earnings release yet.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
CURLF
$6.26 (7.38%) $0.43
Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
CRLBF
$4.09 (2.76%) $0.11

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
330%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/23/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.